HighTower Advisors’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
HighTower Advisors's STIM Position: Q3 2026 in Review
HighTower Advisors increased its Neuronetics (STIM) stake by 95% in Q3 2026, buying an estimated $1.32M and bringing the position to 1,101,502 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1632.
HighTower Advisors first reported a position in STIM in Q3 2020 and has held it in 25 quarters since. 28 funds tracked by Wall St. Rank hold STIM as of Q3 2026.
- HighTower Advisors held 1,101,502 shares of Neuronetics worth $2.58M as of Q3 2026.
- HighTower Advisors bought 537,761 Neuronetics shares in Q3 2026, an estimated $1.32M.
- Neuronetics made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #1632 holding.
- HighTower Advisors first reported a position in Neuronetics in Q3 2020 and has held it in 25 quarters since.
- 28 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.